{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:50:42Z","timestamp":1784173842679,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neures.2025.104940","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:57:08Z","timestamp":1752580628000},"page":"104940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Asfotase alfa restores PLP-dependent GABA, cystathionine, and amino acid metabolism in a mouse model of hypophosphatasia"],"prefix":"10.1016","volume":"218","author":[{"given":"Kathryn N.","family":"Phoenix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Marozsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Liu-Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5440-4666","authenticated-orcid":false,"given":"Lizhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mogha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Brownstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3350-9896","authenticated-orcid":false,"given":"Raja","family":"Padidela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2025.104940_bib1","article-title":"Strensiq [summary of product characteristics]","author":"Alexion Europe SAS","year":"2020","journal-title":"LevolloisPerret Fr."},{"key":"10.1016\/j.neures.2025.104940_bib2","unstructured":"Alexion Pharmaceuticals. 2015. Strensiq (asfotase alfa) receives marketing approval in Japan for treatment of patients with hypophosphatasia (HPP) [press release] [online]. Cheshire, CT: Alexion Pharmaceuticals. Available: https:\/\/www.fiercepharma.com\/pharma-asia\/strensiq%C2%AE-asfotase-alfa-receives-marketing-approval-japan-for-treatment-of-patients [Accessed May 6, 2025]."},{"key":"10.1016\/j.neures.2025.104940_bib3","unstructured":"Alexion Pharmaceuticals, Inc., 2024. Strensiq [package insert], Boston, MA."},{"key":"10.1016\/j.neures.2025.104940_bib4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bone.2007.01.020","article-title":"Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene","volume":"40","author":"Baumgartner-Sigl","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.neures.2025.104940_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jnc.13950","article-title":"Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis","volume":"140","author":"Cruz","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2025.104940_bib6","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1359\/jbmr.1999.14.12.2015","article-title":"Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia","volume":"14","author":"Fedde","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.neures.2025.104940_bib7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.bbapap.2010.10.010","article-title":"Serine hydroxymethyltransferase: a model enzyme for mechanistic, structural, and evolutionary studies","volume":"1814","author":"Florio","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neures.2025.104940_bib8","doi-asserted-by":"crossref","first-page":"14060","DOI":"10.1073\/pnas.94.25.14060","article-title":"Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase","volume":"94","author":"Kash","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2025.104940_bib9","article-title":"Six-year clinical outcomes of enzyme replacement therapy for perinatal lethal and infantile hypophosphatasia in Korea: two case reports","volume":"102","author":"Kim","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neures.2025.104940_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.neures.2025.104940_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13023-024-03048-6","article-title":"Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry","volume":"19","author":"Kishnani","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neures.2025.104940_bib12","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/acscatal.9b03907","article-title":"Catalytic roles of coenzyme pyridoxal-5\u2032-phosphate (PLP) in PLP-dependent enzymes: reaction pathway for methionine-\u03b3-lyase-catalyzed L-methionine depletion","volume":"10","author":"Li","year":"2020","journal-title":"ACS Catal."},{"key":"10.1016\/j.neures.2025.104940_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000531865","article-title":"Clinical profiles of children with hypophosphatasia prior to treatment with enzyme replacement therapy: an observational analysis from the Global HPP Registry","volume":"97","author":"Martos-Moreno","year":"2024","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.neures.2025.104940_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1359\/jbmr.071213","article-title":"Enzyme replacement therapy for murine hypophosphatasia","volume":"23","author":"Millan","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.neures.2025.104940_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1","article-title":"Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia","volume":"208","author":"Narisawa","year":"1997","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.neures.2025.104940_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pediatrneurol.2021.12.009","article-title":"Status epilepticus due to asfotase alfa interruption in perinatal severe hypophosphatasia","volume":"130","author":"Ogawa","year":"2022","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neures.2025.104940_bib17","series-title":"Neural Metabolism In Vivo","article-title":"Glutamate-glutamine cycle and anaplerosis","author":"\u00d6z","year":"2012"},{"key":"10.1016\/j.neures.2025.104940_bib18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/sj.embor.embor914","article-title":"A genomic overview of pyridoxal-phosphate-dependent enzymes","volume":"4","author":"Percudani","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neures.2025.104940_bib19","first-page":"380","article-title":"Hypophosphatasia","volume":"10","author":"Rockman-Greenberg","year":"2013","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.neures.2025.104940_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.33176\/AACB-19-00031","article-title":"Hypophosphatasia: biological and clinical aspects, avenues for therapy","volume":"41","author":"Salles","year":"2020","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.neures.2025.104940_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/abbi.1996.0269","article-title":"Vitamin B6 deficiency accelerates metabolic turnover of cystathionase in rat liver","volume":"330","author":"Sato","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neures.2025.104940_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/iub.1178","article-title":"Strict reaction and substrate specificity of AGXT2L1, the human O-phosphoethanolamine phospho-lyase","volume":"65","author":"Schiroli","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neures.2025.104940_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng0995-45","article-title":"Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6","volume":"11","author":"Waymire","year":"1995","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neures.2025.104940_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia [with Supplementary Appendix]","volume":"1366","author":"Whyte","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neures.2025.104940_bib25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jc.2015-3462","article-title":"Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia","volume":"101","author":"Whyte","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neures.2025.104940_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2019.01.049","article-title":"Natural history of perinatal and infantile hypophosphatasia: a retrospective study","volume":"209","author":"Whyte","year":"2019","journal-title":"J. Pedia"}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010225001233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010225001233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:13:02Z","timestamp":1777507982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010225001233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":26,"alternative-id":["S0168010225001233"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2025.104940","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asfotase alfa restores PLP-dependent GABA, cystathionine, and amino acid metabolism in a mouse model of hypophosphatasia","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2025.104940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104940"}}